LENZ Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

LENZ Therapeutics (Nasdaq: LENZ), a late clinical-stage biopharmaceutical company developing an aceclidine-based eye drop for presbyopia, has announced its participation in several upcoming investor conferences. These include:

• Morgan Stanley 22nd Annual Global Healthcare Conference (New York, NY) on September 4, 2024
• Wells Fargo Securities 2024 Healthcare Conference (Boston, MA) on September 5, 2024
• H.C. Wainwright 26th Annual Global Investment Conference (New York, NY) on September 10, 2024
• Cantor Global Healthcare Conference (New York, NY) on September 18, 2024

Management will engage in one-on-one meetings at all events and deliver corporate presentations at the H.C. Wainwright and Cantor conferences. A live audio webcast of the Cantor presentation will be available on the LENZ website for 90 days, with a 30-day replay option.

News Market Reaction

+0.45%

1 alert

+0.45% News Effect

On the day this news was published, LENZ gained 0.45%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

SAN DIEGO, Aug. 27, 2024 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a late clinical-stage biopharmaceutical company focused on developing the first and only aceclidine-based eye drop that has been shown to improve near vision in people with presbyopia, today announced that company management will participate in the following upcoming investor conferences:

Morgan Stanley 22^nd Annual Global Healthcare Conference (New York, NY)
Management will participate in one-on-one meetings on Wednesday, September 4, 2024.

Wells Fargo Securities 2024 Healthcare Conference (Boston, MA)
Management will participate in one-on-one meetings on Thursday, September 5, 2024.

H.C. Wainwright 26^th Annual Global Investment Conference (New York, NY)
Management is scheduled to provide a corporate presentation on Tuesday, September 10, 2024 at 12:30 PM ET and participate in one-on-one meetings.

Cantor Global Healthcare Conference (New York, NY)
Management is scheduled to provide a corporate presentation on Wednesday, September 18, 2024 at 10:55 AM ET and participate in one-on-one meetings.

A live audio webcast of the Cantor Global Healthcare Conference corporate presentation can be accessed here and on the LENZ Therapeutics website at www.LENZ-tx.com in the Investors & Media section for 90 days following the presentation. A replay of the webcast will be available on the Company’s website for 30 days following the event.

About LENZ Therapeutics
LENZ Therapeutics is a late clinical-stage biopharmaceutical company focused on the development and commercialization of the first and only aceclidine-based eye drop to improve vision in patients with presbyopia. LENZ’s product candidate, LNZ100 is a preservative-free, single-use, once-daily eye drop containing aceclidine. LNZ100 was evaluated in the registration-enabling Phase 3 CLARITY study as a potential therapy for the treatment of presbyopia, a condition impacting an estimated 1.8 billion people globally and 128 million people in the United States. LENZ has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration for the treatment of presbyopia. LENZ is committed to commercializing an ideal pharmaceutical presbyopia solution that enhances vision for “all eyes, all day.” LENZ is headquartered in San Diego, California. For more information, visit: LENZ-Tx.com.

Contacts:

Dan Chevallard
LENZ Therapeutics
IR@LENZ-Tx.com

FAQ

What investor conferences will LENZ Therapeutics attend in September 2024?

LENZ Therapeutics will attend four investor conferences in September 2024: Morgan Stanley Global Healthcare Conference (Sept. 4), Wells Fargo Securities Healthcare Conference (Sept. 5), H.C. Wainwright Global Investment Conference (Sept. 10), and Cantor Global Healthcare Conference (Sept. 18).

Will LENZ Therapeutics give presentations at the investor conferences?

Yes, LENZ Therapeutics management is scheduled to give corporate presentations at two of the four conferences: H.C. Wainwright Global Investment Conference on September 10, 2024, at 12:30 PM ET, and Cantor Global Healthcare Conference on September 18, 2024, at 10:55 AM ET.

Can investors access LENZ Therapeutics' presentation at the Cantor Global Healthcare Conference?

Yes, a live audio webcast of LENZ Therapeutics' presentation at the Cantor Global Healthcare Conference will be available on the company's website (www.LENZ-tx.com) in the Investors & Media section for 90 days following the presentation, with a 30-day replay option.

What is the main focus of LENZ Therapeutics' drug development?

LENZ Therapeutics is focused on developing the first and only aceclidine-based eye drop that has been shown to improve near vision in people with presbyopia.